Human and cell biology
Curated human genetics, cell assays, images, and sequences provide the evidence for a hypothesis. ATLAS-HUMAN and ATLAS-CELL connect disease relevance with measured biological response.
INTELLIGENCE GROUNDED IN BIOLOGY
Canary Atlas AI
Human biology, cellular evidence, AI reasoning, and HYPER-15™ delivery in one experimental loop.
BIOLOGY, AI & DELIVERY
Built for the step after the list.
Human and cellular evidence, agentic reasoning, and HYPER-15™ delivery come together in one experimental loop.
Human + cell biology
Curated evidence in fat and muscle.
Agentic reasoning
Test mechanisms. Name the next experiment.
HYPER-15™ Active Fusion
Target tissue and cargo: siRNA, mRNA, and gene editing.
Turn adipocyte and muscle genetics into deliverable nucleic-acid programs.
BIOLOGY + AI + DELIVERY
Built for the step after the list.
Canary Atlas is designed to turn evidence about adipose tissue and skeletal muscle into nucleic-acid programs that can be tested and delivered. Its purpose is to connect target selection to an actionable experiment, with delivery considered from the start.
Agentic reasoning
OpenAI reasoning is incorporated into the Atlas design to integrate evidence, examine mechanisms, and name the next experiment. Scientific review remains part of the decision.
Enabling delivery
HYPER-15™ Active Fusion LNP is the delivery platform around which cargo and tissue requirements are evaluated. A target must be matched to a feasible delivery approach.
A SHARED DISCOVERY SYSTEM
One approach across four programs.
Atlas sits across the pipeline, bringing human evidence, cell response, and delivery criteria into each program’s next decision.
QuadHub · CCT8103/5
Discovery work on fusion mRNA designs focuses on expression, exposure, and the activity of the intended agonist components.
Energy expenditure · CCT-217
The program investigates combined gene silencing for adipose energy expenditure, with lean-mass preservation and metabolic adaptation among its development objectives.
Muscle · CCT1117
Combined siRNA research evaluates muscle size alongside force and mitochondrial function, including comparison with myostatin silencing alone.
Metabolic restoration · CCT-987
A multimodal siRNA / mRNA program investigates functional adipose rescue through a rare-disease development path. Prader-Willi syndrome is a focus of Canary’s metabolic restoration program.
HYPER-15™ ACTIVE FUSION
Delivery is part of program design.
Intended tissues
Mature adipocytes and skeletal muscle.
Payload scope
siRNA, mRNA, and gene-editing cargo.
Delivery mechanism
Plasma-membrane fusion for cytosolic entry is the design goal.
Repeat dosing
A self-degrading delivery design intended to support chronic use.
These are platform design objectives. Tissue targeting, cargo performance, and repeat-dose suitability require experimental validation.
Explore HYPER-15™“AI without enabling technology is just a list.”Raj Reddy CEO, Canary Cure Therapeutics